Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers I > Headlines for iBio, Inc. > News item |
iBio terminates its $10 million at-the-market share sales agreement
Company says no shares were sold in deal with Further Lane Securities
By Devika Patel
Knoxville, Tenn., May 1 - iBio, Inc. terminated a $10 million at-the-market sales agreement with agent Further Lane Securities, LP on April 26, according to an 8-K and prospectus supplement filed Friday with the Securities and Exchange Commission. The deal was negotiated on Jan. 31.
No shares were sold under the agreement.
The biotechnology company is based in Newark, Del.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.